Chordate Medical (Sweden) Probability of Future Stock Price Finishing Under 6.61
| CMH Stock | 12.55 0.25 1.95% |
Chordate |
Chordate Medical Target Price Odds to finish below 6.61
The tendency of Chordate Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 6.61 or more in 90 days |
| 12.55 | 90 days | 6.61 | about 1.71 |
Based on a normal probability distribution, the odds of Chordate Medical to drop to 6.61 or more in 90 days from now is about 1.71 (This Chordate Medical Holding probability density function shows the probability of Chordate Stock to fall within a particular range of prices over 90 days) . Probability of Chordate Medical Holding price to stay between 6.61 and its current price of 12.55 at the end of the 90-day period is about 6.2 .
Assuming the 90 days trading horizon Chordate Medical has a beta of 0.16 suggesting as returns on the market go up, Chordate Medical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Chordate Medical Holding will be expected to be much smaller as well. Additionally Chordate Medical Holding has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Chordate Medical Price Density |
| Price |
Predictive Modules for Chordate Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Chordate Medical Holding. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Chordate Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Chordate Medical is not an exception. The market had few large corrections towards the Chordate Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Chordate Medical Holding, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Chordate Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.84 | |
β | Beta against Dow Jones | 0.16 | |
σ | Overall volatility | 8.42 | |
Ir | Information ratio | -0.14 |
Chordate Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Chordate Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Chordate Medical Holding can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Chordate Medical generated a negative expected return over the last 90 days | |
| Chordate Medical has high historical volatility and very poor performance | |
| Chordate Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 618.01 K. Net Loss for the year was (19.76 M) with profit before overhead, payroll, taxes, and interest of 1.93 M. | |
| Chordate Medical generates negative cash flow from operations | |
| About 40.0% of the company shares are held by company insiders |
Chordate Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Chordate Stock often depends not only on the future outlook of the current and potential Chordate Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chordate Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 61.1 M | |
| Cash And Short Term Investments | 15.5 M |
Chordate Medical Technical Analysis
Chordate Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Chordate Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Chordate Medical Holding. In general, you should focus on analyzing Chordate Stock price patterns and their correlations with different microeconomic environments and drivers.
Chordate Medical Predictive Forecast Models
Chordate Medical's time-series forecasting models is one of many Chordate Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Chordate Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Chordate Medical Holding
Checking the ongoing alerts about Chordate Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Chordate Medical Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Chordate Medical generated a negative expected return over the last 90 days | |
| Chordate Medical has high historical volatility and very poor performance | |
| Chordate Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 618.01 K. Net Loss for the year was (19.76 M) with profit before overhead, payroll, taxes, and interest of 1.93 M. | |
| Chordate Medical generates negative cash flow from operations | |
| About 40.0% of the company shares are held by company insiders |
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.